NFE2L2 and chronic kidney disease: Again, as previously reported, Aldo treatment in mice did not induce Nrf2 target genes as we previously observed in rats [11,15], consistent with reports of downregulated Nrf2 targets from the human situation in CKD and other animal CKD models [5,16].